EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells


BACKGROUND Glioblastomas (GBM) are often characterized by an elevated expression of the epidermal growth factor receptor variant III (EGFRvIII). We used GBM cell lines with native EGFRvIII expression to determine whether this EGFR variant affects radiosensitivity with or without EGFR targeting. METHODS Experiments were performed with GBM cell lines… (More)
DOI: 10.18632/oncotarget.5293


6 Figures and Tables